A detailed history of Two Sigma Investments, LP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Two Sigma Investments, LP holds 144,181 shares of PRCT stock, worth $4.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
144,181
Previous 348,148 58.59%
Holding current value
$4.28 Million
Previous $20.1 Million 74.34%
% of portfolio
0.01%
Previous 0.04%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$35.69 - $60.06 $7.28 Million - $12.3 Million
-203,967 Reduced 58.59%
144,181 $5.15 Million
Q2 2025

Aug 14, 2025

SELL
$48.82 - $65.05 $6.47 Million - $8.62 Million
-132,543 Reduced 27.57%
348,148 $20.1 Million
Q1 2025

May 15, 2025

BUY
$56.03 - $88.57 $7.11 Million - $11.2 Million
126,975 Added 35.9%
480,691 $28 Million
Q4 2024

Feb 14, 2025

BUY
$67.27 - $99.45 $11.3 Million - $16.8 Million
168,505 Added 90.98%
353,716 $28.5 Million
Q3 2024

Nov 14, 2024

SELL
$56.31 - $84.99 $4.5 Million - $6.79 Million
-79,888 Reduced 30.14%
185,211 $14.8 Million
Q2 2024

Aug 14, 2024

BUY
$45.73 - $69.19 $933,989 - $1.41 Million
20,424 Added 8.35%
265,099 $16.2 Million
Q1 2024

May 15, 2024

BUY
$40.38 - $50.75 $8.08 Million - $10.2 Million
200,157 Added 449.61%
244,675 $12.1 Million
Q4 2023

Feb 14, 2024

BUY
$24.89 - $43.41 $1.11 Million - $1.93 Million
44,518 New
44,518 $1.87 Million
Q1 2023

May 15, 2023

BUY
$26.64 - $39.74 $2.2 Million - $3.29 Million
82,747 New
82,747 $2.35 Million
Q1 2022

May 16, 2022

SELL
$16.89 - $35.74 $139,730 - $295,677
-8,273 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$24.6 - $46.29 $203,515 - $382,957
8,273 New
8,273 $207,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $1.32B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.